• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[心境稳定剂与妊娠结局——综述]

[Mood stabilisers and pregnancy outcomes - a review].

作者信息

Costoloni Giulia, Pierantozzi Elisa, Goracci Arianna, Bolognesi Simone, Fagiolini Andrea

出版信息

Psychiatr Pol. 2014 Sep-Oct;48(5):865-87. doi: 10.12740/pp/25834.

DOI:10.12740/pp/25834
PMID:25639010
Abstract

The purpose of this review is to give useful information to guide clinicians when treating pregnant women affected by bipolar disorder. This review focuses on mood stabilizers including lithium, sodium valproate, carbamazepine, oxcarbazepine, gabapentin, lamotrigine and topiramate. Data have been extracted from a MEDLINE search. Data from prospective, retrospective and case-control studies as well as systematic reviews, meta-analysis and data from Pregnancy Registry were included. Major congenital malformations as well as specific malformations were reported for each drug. Preliminary findings seem to identify lamotrigine as one ofthe safest antiepileptic drugs to be used in pregnancy. Teratogenity risk oftopiramate is still largely unknown and there are not enough studies to draw even preliminary conclusions. Preliminary studies failed to report an increased risk for major congenital malformations among gabapentin or.oxcarbazepine exposed pregnancies. Even if raising less concern when compared to valproate, carbamazepine should be avoided for its documented teratogenity risk. Valproate seems to be the worst considering major congenital malformations, specific malformations as,well as its detrimental effects on neurodevelopment. On the other hand, lithium might be considered a good option when treating pregnant women affected by bipolar disorder. Given the limited research on mood stabilizers in pregnancy, clinicians need to be very careful when treating child bearing age women. Clinicians have to balance the potential teratogenityrisk against that of untreated mental illness considering individual circumstances such as severity of illness and risk of relapse.

摘要

本综述的目的是提供有用信息,以指导临床医生治疗患有双相情感障碍的孕妇。本综述重点关注心境稳定剂,包括锂盐、丙戊酸钠、卡马西平、奥卡西平、加巴喷丁、拉莫三嗪和托吡酯。数据来自MEDLINE检索。纳入了前瞻性、回顾性和病例对照研究的数据,以及系统评价、荟萃分析和妊娠登记处的数据。报告了每种药物的主要先天性畸形以及特定畸形。初步研究结果似乎表明拉莫三嗪是孕期使用的最安全的抗癫痫药物之一。托吡酯的致畸风险在很大程度上仍然未知,而且没有足够的研究得出哪怕是初步结论。初步研究未能报告加巴喷丁或奥卡西平暴露妊娠中主要先天性畸形风险增加。尽管与丙戊酸盐相比引起的担忧较少,但鉴于已记录的致畸风险,应避免使用卡马西平。考虑到主要先天性畸形、特定畸形以及对神经发育的有害影响,丙戊酸盐似乎是最差的选择。另一方面,锂盐可能被认为是治疗患有双相情感障碍孕妇的一个好选择。鉴于孕期心境稳定剂的研究有限,临床医生在治疗育龄妇女时需要非常谨慎。临床医生必须根据个体情况,如疾病严重程度和复发风险,权衡潜在的致畸风险与未治疗精神疾病的风险。

相似文献

1
[Mood stabilisers and pregnancy outcomes - a review].[心境稳定剂与妊娠结局——综述]
Psychiatr Pol. 2014 Sep-Oct;48(5):865-87. doi: 10.12740/pp/25834.
2
Mood stabilizers in pregnancy: a systematic review.妊娠期心境稳定剂:系统评价。
Aust N Z J Psychiatry. 2010 Nov;44(11):967-77. doi: 10.3109/00048674.2010.506637.
3
Mood stabilizers during breastfeeding: a review.母乳喂养期间使用心境稳定剂:一项综述。
J Clin Psychiatry. 2000 Feb;61(2):79-90. doi: 10.4088/jcp.v61n0202.
4
Mood stabilizers in pregnancy and child developmental outcomes: A systematic review.妊娠期心境稳定剂与儿童发育结局:系统评价。
Aust N Z J Psychiatry. 2017 Nov;51(11):1087-1097. doi: 10.1177/0004867417726175. Epub 2017 Aug 20.
5
Lithium Use in Pregnancy and the Risk of Cardiac Malformations.孕期使用锂与心脏畸形风险
N Engl J Med. 2017 Jun 8;376(23):2245-2254. doi: 10.1056/NEJMoa1612222.
6
The safety of medications for the treatment of bipolar disorder during pregnancy and the puerperium.双相情感障碍治疗药物在孕期及产褥期的安全性。
Curr Drug Saf. 2006 Jan;1(1):25-33. doi: 10.2174/157488606775252692.
7
International prescribing patterns for mood illness: the International Mood Network (IMN).情绪疾病的国际处方模式:国际情绪网络(IMN)。
J Affect Disord. 2014;167:136-9. doi: 10.1016/j.jad.2014.05.049. Epub 2014 Jun 2.
8
Treating mood disorders during pregnancy: safety considerations.孕期情绪障碍的治疗:安全性考量
Drug Saf. 2005;28(8):695-706. doi: 10.2165/00002018-200528080-00004.
9
Adverse outcomes during pregnancy and major congenital malformations in infants of patients with bipolar and schizoaffective disorders treated with antiepileptic drugs: A systematic review.双相情感障碍和分裂情感性障碍患者使用抗癫痫药物治疗期间的妊娠不良结局及婴儿严重先天性畸形:一项系统评价。
Psychiatr Pol. 2019 Apr 30;53(2):223-244. doi: 10.12740/PP/105906.
10
Management of bipolar disorder during pregnancy and the postpartum period.孕期及产后双相情感障碍的管理
Am J Psychiatry. 2004 Apr;161(4):608-20. doi: 10.1176/appi.ajp.161.4.608.

引用本文的文献

1
Use of Prescribed Psychotropics during Pregnancy: A Systematic Review of Pregnancy, Neonatal, and Childhood Outcomes.孕期使用处方精神药物:对妊娠、新生儿及儿童期结局的系统评价
Brain Sci. 2019 Sep 14;9(9):235. doi: 10.3390/brainsci9090235.